<?xml version="1.0" encoding="UTF-8"?>
<fig id="ijms-20-06261-f006" orientation="portrait" position="float">
 <label>Figure 6</label>
 <caption>
  <p>Therapeutic effect of NC-5 on mice infected with the oseltamivir-resistant influenza A virus A/FM/1/47-H275Y (H1N1-H275Y). The ICR mice were intranasally infected with H1N1-H275Y virus (8 × LD50), and ten mice in each group received a placebo, NC-5 or oseltamivir phosphate (OS) twice daily for 5 days. (
   <bold>A</bold>) Survival rate. (
   <bold>B</bold>) Body weight monitored daily. On day 5 p.i., five mice per group were euthanized for lung pathology examination and lung index calculation. (
   <bold>C</bold>) Lung indices. (
   <bold>D</bold>) Histological scores (
   <italic>n</italic> = 6). (
   <bold>E</bold>) H &amp; E staining of sectioned lungs. Data are represented as the mean ± S.D. of three independent experiments, * 
   <italic>p</italic> &lt;0.05, ** 
   <italic>p</italic> &lt;0.01, *** 
   <italic>p</italic> &lt;0.001 compared with the placebo group.
  </p>
 </caption>
 <graphic xlink:href="ijms-20-06261-g006" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
